BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

North America

Daiichi Sankyo and AstraZeneca’s ENHERTU Approved in EU for Earlier Treatment of HER2 Low and Ultralow Breast Cancer

Based on DESTINY-Breast06 phase 3 trial results which showed ENHERTU demonstrated superiority versus chemotherapy with a median progression-free surviv...

April 04, 2025 | News

Cytiva Introduces MabSelect SuRe 70 & PrismA X to Boost Cost-Efficient mAb Purification

MabSelect SuRe 70 and MabSelect PrismA X resins to set new standards in affordability and productivity Cytiva's expanded resin portfolio wil...

April 04, 2025 | News

Senhwa’s CX-4945 Shows Promising Disease Control and Durability in Refractory Basal Cell Carcinoma

Basal Cell Carcinoma CSR Highlights CX-4945 Monotherapy: Progression-free survival (PFS) exceeded 21 months in two patients. Optimal Treatment Res...

April 03, 2025 | News

TCI Biotech Elevates CDMO+ Services with US-Based Glass Bottling for Liquid Supplements

TCI Biotech (TCI Co., Ltd.), a CDMO+ organization specializing in health and wellness products, is spotlighting its comprehensive US-based glass bottling s...

April 03, 2025 | News

LBB Specialties Partners with Kerry Group to Distribute Sheffield™ Pharmaceutical Lactose in the U.S.

LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America, is pleased to announce a new par...

April 03, 2025 | News

Thermo Fisher Scientific Launches Krios 5 Cryo-TEM, Setting New Standard in Atomic-Resolution Imaging

Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Krios™ 5 Cryo-TEM. This next-generati...

April 03, 2025 | News

SHL Medical Launches $220M Autoinjector Facility in South Carolina to Boost US Production and Global Supply

SHL Medical, a global leader in the design, development, and manufacturing of advanced self-injection solutions, has officially inaugurated its new state-o...

April 02, 2025 | News

Lunit Collaborates with U.S. National Cancer Institute to Advance AI-Driven Cancer Research

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a collaboration with the Nationa...

April 01, 2025 | News

Thermo Fisher Introduces First Eco-Friendly Floor-Model Centrifuges with Natural Refrigerant Cooling

Thermo Fisher Scientific Inc., the world leader in serving science, introduced today new lines of floor-model centrifuges to provide more sustainable solut...

April 01, 2025 | News

GE HealthCare Launches Vibe CT System to Expand Access to Advanced Cardiac Imaging

GE HealthCare’s Revolution Vibe CTi enables more facilities to elevate patient care by offering advanced cardiac imaging technology that hel...

March 31, 2025 | News

Celltrion’s Biosimilar STEQEYMA® Added to Costco Member Prescription Program to Expand Access and Affordability

STEQEYMA® (ustekinumab-stba) is Celltrion's biosimilar to STELARA® (ustekinumab), which was launched on March 12, 2025 Celltrion'...

March 28, 2025 | News

CJ BIO’s BiomeNrich™ POST M005 Becomes First Akkermansia muciniphila-Based Ingredient to Gain FDA NDIN Acknowledgment

CJ BIO's BiomeNrich™ POST M005 is the first Akkermansia muciniphila-based ingredient to receive New Dietary Ingredient Notification (NDIN) ...

March 28, 2025 | News

Turn Bio Acquires ARMMs Technology to Advance Precision Epigenetic Therapies Across More Tissues and Indications

ARMMs brings precision medicine through targeted, non-viral vesicular delivery Synergy of ARMMs and eTurna™ LNP platforms means company can delive...

March 27, 2025 | News

AnHorn Medicines Doses First Subject in U.S. Phase I Trial for AH-001, a First-in-Class Protein Degrader Targeting Hair Loss

AnHorn Medicines, a pioneering AI-driven new drug discovery company, is pleased to announce that, AH-001, a first-in-class protein degrader for androg...

March 27, 2025 | News

Stay Connected